Australia
# |
Name |
Shareholders' Equity |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 17.33 B
|
June 30, 2024 | USD 169.95 | -0.56% |
|
Australia |
|
2 |
USD 5.28 B
|
June 30, 2024 | USD 17.72 | 0.58% |
|
Australia |
|
3 |
USD 1.64 B
|
June 30, 2024 | USD 23.31 | 1.44% |
|
Australia |
|
4 |
USD 1.53 B
|
Sept. 30, 2024 | USD 2.40 | 4.17% |
|
Australia |
|
5 |
USD 693.90 M
|
June 30, 2024 | USD 0.87 | -0.82% |
|
Australia |
|
6 |
USD 571.82 M
|
Jan. 31, 2024 | USD 1.77 | 0.62% |
|
Australia |
|
7 |
USD 480.36 M
|
June 30, 2024 | USD 1.90 | -4.74% |
|
Australia |
|
8 |
USD 302.83 M
|
June 30, 2024 | USD 2.89 | 2.85% |
|
Australia |
|
9 |
USD 135.36 M
|
June 30, 2024 | USD 7.27 | 0.71% |
|
Australia |
|
10 |
USD 126.37 M
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
|
11 |
USD 101.41 M
|
Dec. 31, 2023 | USD 18.33 | -0.84% |
|
Australia |
|
12 |
USD 48.09 M
|
June 30, 2024 | USD 1.23 | -0.40% |
|
Australia |
|
13 |
USD 21.97 M
|
Dec. 31, 2023 | USD 1.45 | -3.95% |
|
Australia |
|
14 |
USD 19.48 M
|
Dec. 31, 2023 | USD 6.16 | 2.82% |
|
Australia |
The Pharmaceuticals company in Australia with the highest Shareholders' Equity is CSL Limited (ASX: CSL.AX) at USD 17.33 B.
The Pharmaceuticals company in Australia with the lowest Shareholders' Equity is Anteris Technologies Ltd (ASX: AVR.AX) at USD 19.48 M.
The top 10 Pharmaceuticals companies in Australia by Shareholders' Equity are CSL Limited, Sonic Healthcare Limited, EBOS Group Limited, Nufarm Limited, Healius Limited, Sigma Healthcare Limited, Mesoblast Limited, Mayne Pharma Group Limited, Clinuvel Pharmaceuticals Limited and Immutep Limited.
The bottom 10 Pharmaceuticals companies in Australia by Shareholders' Equity are Anteris Technologies Ltd, Cyclopharm Limited, PolyNovo Limited, Telix Pharmaceuticals Limited, Immutep Limited, Clinuvel Pharmaceuticals Limited, Mayne Pharma Group Limited, Mesoblast Limited, Sigma Healthcare Limited and Healius Limited.